{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:37:12Z","timestamp":1777415832472,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,25]],"date-time":"2008-07-25T00:00:00Z","timestamp":1216944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00277-008-0541-5","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T03:40:00Z","timestamp":1216870800000},"page":"85-88","source":"Crossref","is-referenced-by-count":14,"title":["A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia"],"prefix":"10.1007","volume":"88","author":[{"given":"Adrian","family":"Tempescul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Feuerbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Ianotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Dalbies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Marion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9e","family":"Le Bris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"De Braekeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Berthou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,25]]},"reference":[{"issue":"4","key":"541_CR1","first-page":"RA69","volume":"13","author":"T Robak","year":"2007","unstructured":"Robak T, Robak P (2007) Current treatment options in prolymphocytic leukaemia. Med Sci Monit 13(4):RA69\u2013RA80","journal-title":"Med Sci Monit"},{"issue":"2","key":"541_CR2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cancergencyto.2003.09.009","volume":"150","author":"P Kuriakose","year":"2004","unstructured":"Kuriakose P, Perveen N, Maeda K, Wiktor A, Van Dyke DL (2004) Translocations (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukaemia. Cancer Genet Cytogenet 150(2):156\u2013158","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"541_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2006.06.010","volume":"31","author":"RH Crisostomo","year":"2007","unstructured":"Crisostomo RH, Fernandez JA, Caceres W (2007) Complex caryotype including chromosomal translocation (8;14)(q24;q32) in one case with B-cell prolymphocutic leukaemia. Leuk Res 31(5):699\u2013701 doi: 10.1016\/j.leukres.2006.06.010","journal-title":"Leuk Res"},{"issue":"1","key":"541_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cancergencyto.2004.09.016","volume":"159","author":"F Nguyen-Khac","year":"2005","unstructured":"Nguyen-Khac F, Davi F, Receveur A, Maloum K, Morel V, Le Garff-Tavernier M et al (2005) Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin. Cancer Genet Cytogenet 159(1):74\u201378 doi: 10.1016\/j.cancergencyto.2004.09.016","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"541_CR5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/10428190109097717","volume":"42","author":"C Hercher","year":"2001","unstructured":"Hercher C, Robain M, Davi F, Garand R, Flandrin G, Valensi F et al (2001) Groupe Fran\u00e7ais d'H\u00e9matologie Cellulaire\u2014\u201cA multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms\u201d. Leuk Lymphoma 42(5):981\u2013987 doi: 10.3109\/10428190109097717","journal-title":"Leuk Lymphoma"},{"issue":"1\u20132","key":"541_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10428199909093739","volume":"33","author":"L Shvidel","year":"1999","unstructured":"Shvidel L, Shtalrid M, Bassous L, Klepfish A, Vorst E, Berrebi A (1999) B-cell prolymphocytic leukaemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma 33(1\u20132):169\u2013179","journal-title":"Leuk Lymphoma"},{"key":"541_CR7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/1097-0142(19820415)49:8<1524::AID-CNCR2820490803>3.0.CO;2-U","volume":"49","author":"HG Taylor","year":"1982","unstructured":"Taylor HG, Butler WM, Rhoads J, Karcher DS, Detrick-Hooks B (1982) Prolymphocytic leukemia: Treatment with combination chemotherapy to include doxorubicin. Cancer 49:1524\u20131529 doi: 10.1002\/1097-0142(19820415)49:8<1524::AID-CNCR2820490803>3.0.CO;2-U","journal-title":"Cancer"},{"issue":"3","key":"541_CR8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1979.tb01159.x","volume":"42","author":"R Sibbald","year":"1979","unstructured":"Sibbald R, Catovsky D (1979) Complete remission in prolymphocytic leukaemia with the combination chemotherapy CHOP. Br J Haematol 42(3):488\u2013490 doi: 10.1111\/j.1365-2141.1979.tb01159.x","journal-title":"Br J Haematol"},{"key":"541_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cncr.11000","volume":"97","author":"M Montillo","year":"2003","unstructured":"Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A et al (2003) Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Cancer 97:114\u2013120 doi: 10.1002\/cncr.11000","journal-title":"Cancer"},{"issue":"5","key":"541_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00277-003-0805-z","volume":"83","author":"YA Mourad","year":"2004","unstructured":"Mourad YA, Taher A, Chehal A, Shamseddine A (2004) Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody. Ann Hematol 83(5):319\u2013321 doi: 10.1007\/s00277-003-0805-z","journal-title":"Ann Hematol"},{"issue":"1","key":"541_CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/10428190210178","volume":"43","author":"J Perz","year":"2002","unstructured":"Perz J, Topaly J, Fruehauf S, Hensel M, Ho AD (2002) Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia. Leuk Lymphoma 43(1):149\u2013151 doi: 10.1080\/10428190210178","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"541_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.20843","volume":"82","author":"BT Chaar","year":"2007","unstructured":"Chaar BT, Petruska PJ (2007) Complete response to Alemtuzumab in a patient with B prolymphocytic leukaemia. Am J Hematol 82(5):417 doi: 10.1002\/ajh.20843","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0541-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0541-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:45:02Z","timestamp":1559036702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0541-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,25]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0541-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,25]]}}}